Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SRNE Gross Margin

The Gross Margin of Sorrento Therapeutics Inc (SRNE) is 46.82%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

SRNE Gross Margin - Historical Value
Date Value
2022-12-31 46.82%
2021-12-31 75.43%
2020-12-31 75.00%
2019-12-31 61.15%
2018-12-31 66.51%
2017-12-31 97.37%
2016-12-31 89.02%
2015-12-31 56.52%
2014-12-31 47.37%
2013-12-31 100.00%
SRNE Gross Margin - Peers Comparison